Inventor

LIU DACHUN

US41 patents

⚠️ This page may combine multiple inventors who share the name “LIU DACHUN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

ABBVIE INC

21 patents

US8980879B2Mar 17, 2015

Bromodomain inhibitors

ABBVIE INC11 citations83

US9493411B2Nov 15, 2016

Pyrrole-3-carboxamide bromodomain inhibitors

ABBVIE INC3 citations72

US9321764B2Apr 26, 2016

Dihydro-pyrrolopyridinone inhibitors

ABBVIE INC3 citations72

US9296741B2Mar 29, 2016

Bromodomain inhibitors

ABBVIE INC7 citations72

US9050346B2Jun 9, 2015

Bromodomain inhibitors

ABBVIE INC5 citations72

US9006387B2Apr 14, 2015

Anti-viral compounds

ABBVIE INC4 citations72

US10633379B2Apr 28, 2020

Bromodomain inhibitors

ABBVIE INC4 citations71

US9561231B2Feb 7, 2017

Pyridinone and pyridazinone derivatives

ABBVIE INC4 citations71

US10131657B2Nov 20, 2018

Bromodomain inhibitors

ABBVIE INC2 citations69

US9957263B2May 1, 2018

Bromodomain inhibitors

ABBVIE INC3 citations69

US9994581B2Jun 12, 2018

Bromodomain inhibitors

ABBVIE INC2 citations62

US9139536B2Sep 22, 2015

Anti-infective agents and uses thereof

ABBVIE INC2 citations62

US9095590B2Aug 4, 2015

Anti-infective agents and uses thereof

ABBVIE INC3 citations62

US9776990B2Oct 3, 2017

Isoindolone derivatives

ABBVIE INC1 citations52

US9637478B2May 2, 2017

Antiviral compounds and uses thereof

ABBVIE INC0 citations52

US9353091B2May 31, 2016

Antiviral compounds and uses thereof

ABBVIE INC0 citations52

US10039754B2Aug 7, 2018

Anti-viral compounds

ABBVIE INC0 citations51

US10028937B2Jul 24, 2018

Anti-viral compounds

ABBVIE INC0 citations51

US9586978B2Mar 7, 2017

Anti-viral compounds

ABBVIE INC0 citations51

US9567355B2Feb 14, 2017

Hepatitis C inhibitors and uses thereof

ABBVIE INC0 citations51

US9453007B2Sep 27, 2016

Hepatitis C inhibitors and uses thereof

ABBVIE INC0 citations51

ABBOTT LAB

5 patents

US7910595B2Mar 22, 2011

Anti-viral compounds

ABBOTT LAB18 citations83

US7378414B2May 27, 2008

Anti-infective agents

ABBOTT LAB17 citations82

US7915411B2Mar 29, 2011

Anti-viral compounds

ABBOTT LAB3 citations61

US7538105B2May 26, 2009

Anti-infective agents

ABBOTT LAB0 citations50

US7902203B2Mar 8, 2011

Anti-infective agents

ABBOTT LAB0 citations39

DEGOEY DAVID A

3 patents

US8691938B2Apr 8, 2014

Anti-viral compounds

DEGOEY DAVID A26 citations91

US8937150B2Jan 20, 2015

Anti-viral compounds

DEGOEY DAVID A11 citations83

US8921514B2Dec 30, 2014

Anti-viral compounds

DEGOEY DAVID A1 citations51

WAGNER ROLF

2 patents

US8415351B2Apr 9, 2013

Anti-infective agents and uses thereof

WAGNER ROLF37 citations93

US8685991B2Apr 1, 2014

Anti-infective agents and uses thereof

WAGNER ROLF4 citations72

DONNER PAMELA L

2 patents

US8178548B2May 15, 2012

Anti-infective agents and uses thereof

DONNER PAMELA L4 citations60

US8986740B2Mar 24, 2015

Anti-infective agents and uses thereof

DONNER PAMELA L0 citations50

FLENTGE CHARLES A

1 patent

US8501238B2Aug 6, 2013

Anti-infective agents and uses thereof

FLENTGE CHARLES A21 citations90

FLENGTE CHARLES A

1 patent

US8188104B2May 29, 2012

Anti-infective agents and uses thereof

FLENGTE CHARLES A9 citations79

HRAIN BIOTECHNOLOGY CO LTD

1 patent

US11957717B2Apr 16, 2024

Anti-human MSLN antibody and MSLN-targeting immune effector cell

HRAIN BIOTECHNOLOGY CO LTD0 citations49

BETEBENNER DAVID A

1 patent

US8748443B2Jun 10, 2014

Antiviral compounds and uses thereof

BETEBENNER DAVID A0 citations48

UNIV KUNMING SCIENCE & TECHNOLOGY

1 patent

US10982299B2Apr 20, 2021

Method for comprehensively processing noble lead

UNIV KUNMING SCIENCE & TECHNOLOGY0 citations46

MARING CLARENCE J

1 patent

US9173887B2Nov 3, 2015

Hepatitis C inhibitors and uses thereof

MARING CLARENCE J0 citations43

ROCKWAY TODD W

1 patent

US8741914B2Jun 3, 2014

Antiviral compounds and uses thereof

ROCKWAY TODD W0 citations36

GREEN BRIAN E

1 patent

US8497275B2Jul 30, 2013

HCV protease inhibitors and uses thereof

GREEN BRIAN E0 citations32